T4-BSA is an antigen-adjuvant conjugate that combines with bovine serum albumin (BSA). This conjugation enhances the production of antigen-specific antibodies in vaccine models by linking the antigen with a protein adjuvant. The conjugate maintains protein folding and does not disrupt primary epitopes, while also promoting cross-presentation and the generation of antigen-specific T cells.